AxoGen Inc
NASDAQ:AXGN

Watchlist Manager
AxoGen Inc Logo
AxoGen Inc
NASDAQ:AXGN
Watchlist
Price: 13.34 USD 1.83% Market Closed
Market Cap: 587.1m USD
Have any thoughts about
AxoGen Inc?
Write Note

Intrinsic Value

The intrinsic value of one AXGN stock under the Base Case scenario is 9.97 USD. Compared to the current market price of 13.34 USD, AxoGen Inc is Overvalued by 25%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AXGN Intrinsic Value
9.97 USD
Overvaluation 25%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
AxoGen Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for AXGN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about AXGN?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
AxoGen Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about AxoGen Inc

Provide an overview of the primary business activities
of AxoGen Inc.

What unique competitive advantages
does AxoGen Inc hold over its rivals?

What risks and challenges
does AxoGen Inc face in the near future?

Has there been any significant insider trading activity
in AxoGen Inc recently?

Summarize the latest earnings call
of AxoGen Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for AxoGen Inc.

Provide P/S
for AxoGen Inc.

Provide P/E
for AxoGen Inc.

Provide P/OCF
for AxoGen Inc.

Provide P/FCFE
for AxoGen Inc.

Provide P/B
for AxoGen Inc.

Provide EV/S
for AxoGen Inc.

Provide EV/GP
for AxoGen Inc.

Provide EV/EBITDA
for AxoGen Inc.

Provide EV/EBIT
for AxoGen Inc.

Provide EV/OCF
for AxoGen Inc.

Provide EV/FCFF
for AxoGen Inc.

Provide EV/IC
for AxoGen Inc.

Show me price targets
for AxoGen Inc made by professional analysts.

What are the Revenue projections
for AxoGen Inc?

How accurate were the past Revenue estimates
for AxoGen Inc?

What are the Net Income projections
for AxoGen Inc?

How accurate were the past Net Income estimates
for AxoGen Inc?

What are the EPS projections
for AxoGen Inc?

How accurate were the past EPS estimates
for AxoGen Inc?

What are the EBIT projections
for AxoGen Inc?

How accurate were the past EBIT estimates
for AxoGen Inc?

Compare the revenue forecasts
for AxoGen Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of AxoGen Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of AxoGen Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of AxoGen Inc compared to its peers.

Compare the P/E ratios
of AxoGen Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing AxoGen Inc with its peers.

Analyze the financial leverage
of AxoGen Inc compared to its main competitors.

Show all profitability ratios
for AxoGen Inc.

Provide ROE
for AxoGen Inc.

Provide ROA
for AxoGen Inc.

Provide ROIC
for AxoGen Inc.

Provide ROCE
for AxoGen Inc.

Provide Gross Margin
for AxoGen Inc.

Provide Operating Margin
for AxoGen Inc.

Provide Net Margin
for AxoGen Inc.

Provide FCF Margin
for AxoGen Inc.

Show all solvency ratios
for AxoGen Inc.

Provide D/E Ratio
for AxoGen Inc.

Provide D/A Ratio
for AxoGen Inc.

Provide Interest Coverage Ratio
for AxoGen Inc.

Provide Altman Z-Score Ratio
for AxoGen Inc.

Provide Quick Ratio
for AxoGen Inc.

Provide Current Ratio
for AxoGen Inc.

Provide Cash Ratio
for AxoGen Inc.

What is the historical Revenue growth
over the last 5 years for AxoGen Inc?

What is the historical Net Income growth
over the last 5 years for AxoGen Inc?

What is the current Free Cash Flow
of AxoGen Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for AxoGen Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
AxoGen Inc

Current Assets 86.3m
Cash & Short-Term Investments 24.5m
Receivables 24.6m
Other Current Assets 37.1m
Non-Current Assets 105.7m
PP&E 100.5m
Intangibles 5.2m
Current Liabilities 23m
Accounts Payable 21.2m
Accrued Liabilities 1.9m
Other Current Liabilities 6k
Non-Current Liabilities 69.5m
Long-Term Debt 47.3m
Other Non-Current Liabilities 22.3m
Efficiency

Earnings Waterfall
AxoGen Inc

Revenue
180.9m USD
Cost of Revenue
-43.2m USD
Gross Profit
137.7m USD
Operating Expenses
-146.2m USD
Operating Income
-8.5m USD
Other Expenses
-5.8m USD
Net Income
-14.3m USD

Free Cash Flow Analysis
AxoGen Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

AXGN Profitability Score
Profitability Due Diligence

AxoGen Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROIC is Increasing
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
31/100
Profitability
Score

AxoGen Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

AXGN Solvency Score
Solvency Due Diligence

AxoGen Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Average Altman Z-Score
52/100
Solvency
Score

AxoGen Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AXGN Price Targets Summary
AxoGen Inc

Wall Street analysts forecast AXGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AXGN is 17.92 USD with a low forecast of 16.16 USD and a high forecast of 21 USD.

Lowest
Price Target
16.16 USD
21% Upside
Average
Price Target
17.92 USD
34% Upside
Highest
Price Target
21 USD
57% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for AXGN?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for AXGN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

AXGN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

AxoGen Inc Logo
AxoGen Inc

Country

United States of America

Industry

Health Care

Market Cap

587m USD

Dividend Yield

0%

Description

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 428 full-time employees. Its platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Avive Soft Tissue Membrane and Axotouch Two-Point Discriminator. Its products are used by surgeons during surgical interventions to repair a variety of physical nerve damage or transection throughout the body, which ranges from a simple laceration of a finger to a complex brachial plexus injury, as well as nerve injuries caused by dental, orthopedic, and other surgical procedures. Its Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Its portfolio of products is available in the United States, Canada, Germany, Spain, South Korea, and several other countries.

Contact

FLORIDA
Alachua
13631 Progress Blvd Ste 400
+13864626817.0
www.axogeninc.com

IPO

1986-12-17

Employees

428

Officers

Chief Financial Officer
Mr. Nir Naor C.F.A., CPA, L.L.M., M.B.A.
Advisor
Ms. Karen Zaderej
Chief Innovation Officer
Mr. Erick DeVinney
Vice President of Operations
Mr. Todd Puckett
Vice President of Finance & Investor Relations
Mr. Harold D. Tamayo
Executive VP, General Counsel & Chief Compliance Officer
Mr. Marc A. Began
Show More
Vice President of Sales
Ms. Doris Quackenbush
Chief Marketing Officer
Mr. Jens Schroeder Kemp
Chief Medical Officer
Dr. Ivica Ducic M.D., Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one AXGN stock?

The intrinsic value of one AXGN stock under the Base Case scenario is 9.97 USD.

Is AXGN stock undervalued or overvalued?

Compared to the current market price of 13.34 USD, AxoGen Inc is Overvalued by 25%.

Back to Top